Manila Times Business
Quantum BioPharma Provides Corporate Update
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. TORONTO, June 01, 2026 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) ("Quantum” or the "Company”), a biopharmaceutical company focused on advancing innovative therapies and technologies, today provided an update regarding its Investigational New Drug application for Lucid-21-302 (Lucid-MS),
This is an excerpt. Read the full article at the original source:
Source: manilatimes.net
Read Full Article on manilatimes.net →More from Manila Times Business
Mesabi Metallics Monetizes Portion of Royalty Interest for $265 Million
1h ago
At COMPUTEX 2026, YPlasma Unveils the First Fanless Solid-State Cooling for NVIDIA Jetson
1h ago
Traction Uranium Announces Filing of NI 43-101 Technical Report for the Aurora Uranium Project, Saskatchewan
1h ago
Ricoh Asia Pacific acquires Global Vision Multimedia, advancing Ricoh's global workplace services strategy
2h ago